You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,576,156


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,576,156 protect, and when does it expire?

Patent 10,576,156 protects NEFFY and is included in one NDA.

This patent has seventy patent family members in twenty-eight countries.

Summary for Patent: 10,576,156
Title:Compositions for drug administration
Abstract:The present invention provides compositions and methods and for increasing the bioavailability of therapeutic agents in a subject. The compositions include at least one alkyl glycoside and at least one therapeutic agent, wherein the alkylglycoside has an alkyl chain length from about 10 to about 16 carbon atoms.
Inventor(s):Maggio Edward T.
Assignee:Aegis Therapeutics, LLC
Application Number:US15890131
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

United States Patent 10,576,156: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 10,576,156, titled "Compositions for drug administration," is a patent that focuses on innovative methods and compositions for delivering drugs. This analysis will delve into the scope and claims of the patent, as well as the broader patent landscape in which it resides.

Patent Overview

Title and Abstract

The patent, titled "Compositions for drug administration," involves the development of specific compositions designed to enhance the delivery of drugs. The abstract outlines the invention's focus on creating formulations that improve the efficacy, stability, and patient compliance of drug administration[2].

Scope of the Patent

Claims

The patent includes multiple claims that define the scope of the invention. These claims typically cover various aspects of the compositions, including the types of drugs, the formulation components, and the methods of administration. For instance, the claims might specify the use of particular excipients, the concentration of the active pharmaceutical ingredient, and the method of preparing the composition.

Independent and Dependent Claims

Independent claims, such as Claim 1, are crucial as they define the broadest scope of the invention. Dependent claims build upon these independent claims, adding more specific details and narrowing the scope. This hierarchical structure helps in defining the full range of protection afforded by the patent[4].

Key Components of the Invention

Drug Delivery Mechanisms

The patent likely details various mechanisms for drug delivery, such as oral, subcutaneous, or transdermal routes. Each mechanism may involve specific formulations and components tailored to enhance the delivery and absorption of the drug.

Formulation Components

The compositions may include a variety of components such as excipients, stabilizers, and solubilizers. These components are chosen to optimize the drug's stability, bioavailability, and patient compliance.

Patentability Requirements

Novelty, Nonobviousness, and Utility

To be patentable, the invention must meet the requirements of novelty, nonobviousness, and utility. The patent application must demonstrate that the claimed invention is new and different from the prior art, that it would not have been obvious to a person skilled in the art, and that it has a significant and presently available benefit to the public[4].

Written Description, Enablement, and Best Mode

The patent specification must meet the written description, enablement, and best mode requirements. This means the specification must reasonably convey that the inventor had possession of the claimed subject matter, teach those skilled in the art how to make and use the full scope of the claimed invention without undue experimentation, and demonstrate the best mode of practicing the claimed invention at the time of filing[4].

Patent Landscape

Pharmaceutical Patent Trends

The pharmaceutical industry is highly active in patent filings, with a focus on innovative drug delivery systems. The landscape includes a wide range of patents covering various aspects of drug formulation, delivery mechanisms, and therapeutic applications.

Competitors and Market Players

Companies like AbbVie, Pfizer, and Johnson & Johnson are significant players in the pharmaceutical patent landscape. These companies continuously file and secure patents to protect their innovations in drug delivery and formulation[1].

Recent Developments and Trends

Recent trends in pharmaceutical patents include an increased focus on personalized medicine, gene therapy, and advanced drug delivery systems. The use of nanotechnology, liposomes, and other advanced formulations is becoming more prevalent[4].

Blockchain and Pharmaceutical Patents

Intersection of Technologies

While blockchain technology is not directly related to the specific patent in question, it is worth noting that blockchain is increasingly being integrated into various aspects of the pharmaceutical industry, such as supply chain management and data security. However, the patentability of blockchain inventions follows different guidelines, such as the Alice-Mayo test, which assesses whether the claim is directed to an abstract idea or a judicial exception[3].

Practical Implications

Protection and Enforcement

The patent provides its holder with the right to take action against anyone who makes, uses, offers to sell, or sells the patented invention without permission. This protection is crucial for maintaining market exclusivity and preventing unauthorized use of the invention[4].

Licensing and Collaboration

Patent holders can also use their patents as leverage for licensing agreements or collaborations with other companies. This can be particularly beneficial in the pharmaceutical industry, where partnerships can accelerate the development and commercialization of new drugs.

Key Takeaways

  • Scope and Claims: The patent defines specific compositions and methods for drug delivery, with claims that outline the scope of protection.
  • Patentability Requirements: The invention must meet novelty, nonobviousness, and utility requirements, along with written description, enablement, and best mode standards.
  • Patent Landscape: The pharmaceutical industry is highly competitive, with numerous companies filing patents for innovative drug delivery systems.
  • Practical Implications: The patent provides legal protection and can be used for licensing and collaboration.

FAQs

Q: What is the main focus of United States Patent 10,576,156?

A: The main focus is on compositions and methods for enhancing drug delivery, including specific formulations and administration routes.

Q: What are the key components of the invention?

A: The key components include the types of drugs, formulation components such as excipients and stabilizers, and the methods of administration.

Q: How does the patent meet the requirements for patentability?

A: The patent must demonstrate novelty, nonobviousness, and utility, and meet the written description, enablement, and best mode requirements.

Q: Who are the major players in the pharmaceutical patent landscape?

A: Major players include companies like AbbVie, Pfizer, and Johnson & Johnson, which are actively filing and securing patents in the field.

Q: How can the patent be used practically?

A: The patent can be used to protect market exclusivity, enforce against unauthorized use, and facilitate licensing agreements or collaborations.

Sources

  1. USPTO: SANDOZ v. Abbvie IPR2018-00156 Paper 11.pdf
  2. PubChem: Compositions for drug administration - Patent US-10576156-B2
  3. Mintz: Is Your Blockchain Invention Patentable?
  4. CRS Reports: Patent Law: A Primer and Overview of Emerging Issues

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,576,156

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Ars Pharms Operation NEFFY epinephrine SPRAY;NASAL 214697-001 Aug 9, 2024 RX Yes Yes 10,576,156 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,576,156

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2009329952 ⤷  Subscribe
Australia 2011317202 ⤷  Subscribe
Australia 2019217643 ⤷  Subscribe
Australia 2021254650 ⤷  Subscribe
Australia 2024201523 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.